An innovative
adherence partner
Our journey
Mevia is a Gothenburg-based company and an innovative partner to life science companies in solving the problem of medication non-adherence through a reliable, customisable, and user-friendly end-to-end solution.
2015
Mevia’s solution was first tested in real-world studies in the UK and Nordics. Showing great customer satisfaction and improving adherence.
2014
Mevia’s journey began as a spin-off from Chalmers Technical University with a vision to solve the problem of non-adherence.
2017
Mevia enters a collaboration with Jones Healthcare Group. Aiming to bring real-time adherence cards to North America and Europe.
2020
Mevia integrates with one of the largest CROs globally enabling real-time adherence data in clinical trials, continuing its journey to be a leading adherence partner to different healthcare actors.
Our Management team
-
Founder and CEO
jesper@mevia.se
-
CTO
jesper.lugner@mevia.se
“
Mevia is a trusted partner to Merck in a global multicentre clinical study where they support patient adherence and safe data management
Merck KGaA, Darmstadt, Germany
“
With Mevia’s unique and sustainable adherence hardware solution, we have found an ideal partner in enhancing the quality of real-time adherence data.
AARDEX Group - Medication Adherence Tools
“
Mevia's collaborative and responsive approach enables us to improve products and services for our customers and their patients
Jones healthcare group
The board
-
Mikael Sander
Chairman of the board
-
Jonas Bergman
Board member
-
Caroline Pamp
Board member
-
Catharina Gustafsson
Board member
-
Patrik Mossberg
Board member